Cargando…

Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA

INTRODUCTION: From an oncologic perspective, genetic detection is becoming a frontline clinical test, used to identify actionable alterations for targeted therapy, monitor molecular clonal tumor evolution, indicate disease progression and prognosis, and predict medication efficacy and resistance. Fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jie, Chen, Siwen, Xue, Hui, Wang, Haoyi, Huang, Tianwei, Xie, Hongya, He, Jiang, Ke, Cai, Yu, Zhaonan, Ni, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126294/ https://www.ncbi.nlm.nih.gov/pubmed/35615557 http://dx.doi.org/10.2147/OTT.S351085

Ejemplares similares

Bacteria-free minicircle DNA system to generate integration-free CAR-T cells
por: Cheng, Chen, et al.
Publicado: (2019)

Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer
por: Zhang, Meichun, et al.
Publicado: (2022)

Nuclease deficiencies alter plasma cell-free DNA methylation profiles
por: Han, Diana S.C., et al.
Publicado: (2021)

Cell-free DNA in non-small cell lung cancer
por: Gedvilaitė, Vaida, et al.
Publicado: (2017)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
por: Chae, Young Kwang, et al.
Publicado: (2016)

Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Wang, Yongsheng, et al.
Publicado: (2021)

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
por: Su, Yan, et al.
Publicado: (2019)

Detection of copy number alterations in cell-free tumor DNA from plasma
por: Østrup, Olga, et al.
Publicado: (2017)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary
por: Kato, Shumei, et al.
Publicado: (2021)

Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma
por: Guo, Wenbo, et al.
Publicado: (2021)

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
por: Abramson, David H., et al.
Publicado: (2021)

Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring
por: Li, Shuo, et al.
Publicado: (2023)

Analysis of KRAS Mutation Subtype in Tissue DNA and Cell-Free DNA Using Droplet Digital PCR and the Function of Cell-Free DNA as a Recurrence Predictive Marker in Pancreatic Cancer
por: Jun, Eunsung, et al.
Publicado: (2021)

Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2023)

Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
por: Jahangiri, Leila, et al.
Publicado: (2019)

Urine cell‐free DNA as a promising biomarker for early detection of non‐small cell lung cancer
por: Ren, Sai, et al.
Publicado: (2020)

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
por: Cho, Byoung Chul, et al.
Publicado: (2022)

Analysis of the role of DAMTC in lung adenocarcinoma cells based on the DNA microarrays
por: Wang, Binliang, et al.
Publicado: (2019)

Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer
por: Chen, Xin, et al.
Publicado: (2023)

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
por: Bach, Sander, et al.
Publicado: (2021)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Quantitative characterization of tumor cell-free DNA shortening
por: Guo, Juntang, et al.
Publicado: (2020)

Cell-free DNA and outcome in sepsis
por: Rhodes, Andrew, et al.
Publicado: (2012)

Phenotypes from cell-free DNA
por: Zukowski, Alexis, et al.
Publicado: (2020)

Cell-Free DNA in the Investigation of Miscarriage
por: Colley, Emily, et al.
Publicado: (2020)

Cell-Free DNA in Rheumatoid Arthritis
por: Hashimoto, Teppei, et al.
Publicado: (2021)

Brain-derived cell-free DNA
por: Southwood, Dean, et al.
Publicado: (2022)

Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
por: Jensen, Taylor J., et al.
Publicado: (2021)

Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA
por: Zuo, Zhigang, et al.
Publicado: (2020)

Cell-Free Fetal DNA and Cell-Free Total DNA Levels in Spontaneous Abortion with Fetal Chromosomal Aneuploidy
por: Lim, Ji Hyae, et al.
Publicado: (2013)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Clinical significance of plasma free DNA in patients with non-small cell lung cancer
por: Ma, Lanxiang, et al.
Publicado: (2019)

Cell-Free DNA Tissue Damage Mapping in Transplant Patients Infected with COVID-19
por: Andargie, T.E., et al.
Publicado: (2021)

Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
por: Tsoi, Kim M., et al.
Publicado: (2021)

Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures
por: Oberhofer, Angela, et al.
Publicado: (2022)

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19
por: Jin, Xin, et al.
Publicado: (2023)

LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA
por: Sato, Hiroki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v5ao6mcic862ti48m7ta2o0caq